J. Goldman & Co LP - 30 Jun 2025 SCHEDULE 13G Report for EAGLE PHARMACEUTICALS, INC. Common Stock (EGRX)

Filing Manager: J. Goldman & Co LP
Reporting Manager: J. Goldman & Co LP
Security: EAGLE PHARMACEUTICALS, INC. Common Stock
Symbol: EGRX
Shares outstanding: 13.1M shares
Disclosed Ownership: 667K shares
Ownership: 5.1%
Form type: SCHEDULE 13G
Filing time: 14 Aug 2025, 20:08:15 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
J. Goldman & Co LP	5.1%	667K	0	667K	Sagan A. Weiss	CCO
J. Goldman Capital Management, Inc.	5.1%	667K	0	667K	Jay G. Goldman	Director
GOLDMAN JAY G	5.1%	667K	0	667K	Jay G. Goldman	N/A